ANDREW PRELLETZ: Open Payments
NPI 1487006482 · LINDENHURST, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,847 in 85 payments from 17 companies in 2025. Trend: 2023 $1,297 · 2024 $1,676 · 2025 $1,847
Food & beverage: $1,847
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $493 |
| ABBVIE INC. | 11 | $252 |
| PFIZER INC. | 10 | $231 |
| AstraZeneca Pharmaceuticals LP | 9 | $166 |
| Lilly USA, LLC | 8 | $163 |
| Exact Sciences Corporation | 4 | $112 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $79 |
| SANOFI PASTEUR INC. | 2 | $72 |
| Merck Sharp & Dohme LLC | 3 | $59 |
| Astellas Pharma US Inc | 2 | $47 |
Products named: Wegovy, MOUNJARO, NURTEC ODT, VRAYLAR, PREVNAR 20, QULIPTA, JARDIANCE, Ozempic.
Industry payments across IL — which companies pay providers there.
